Intranasal lidocaine is delivered to the back of the nasal cavity, where it numbs a cluster of nerves called the sphenopalatine ganglion. This nerve block is used for migraines, cluster headaches, facial pain syndromes, and post-procedure headaches. The technique varies depending on the delivery method, but the core goal is always the same: get the lidocaine solution to the mucosa behind the middle nasal turbinate, where it can reach those nerves. Numbness typically begins within about 90 seconds of application, with full anesthesia achieved by roughly 2 minutes.
Choosing a Delivery Method
There are three common approaches to getting lidocaine into the nasal cavity, each with trade-offs in precision, cost, and ease of use.
Mucosal atomization device (MAD): This is a small plastic tip that attaches to a standard syringe and converts liquid into a fine mist. The MAD Nasal device (made by Teleflex) is the most widely used. It creates broad mucosal coverage without requiring precise aim, making it the simplest option for most clinical settings. Typical dosing with a MAD is 30 to 60 mg of lidocaine per nostril using a 2% solution.
Cotton-tipped applicators: A long, flexible cotton swab is soaked in lidocaine and advanced along the nasal passage until it rests against the back wall of the nasopharynx, posterior to the middle turbinate. The applicator is left in place for 10 to 30 minutes. This method delivers more concentrated contact with the target tissue but is less comfortable for the patient.
Soaked gauze compresses: Convoluted gauze strips soaked in lidocaine 2% are placed into both nasal cavities and left for 10 to 30 minutes. This approach uses higher doses, around 100 mg per nostril, compared to atomization. It provides prolonged mucosal contact but is bulkier and less tolerable.
Drops or spray: A metered-dose spray bottle or simple nasal drops can deliver 0.5 to 2 mL of 4% lidocaine per nostril. Several clinical trials for migraine have used 0.5 mL of 4% lidocaine delivered as drops, relying on gravity and head positioning to guide the solution to the target area.
Step-by-Step Technique With a MAD
Draw the appropriate volume of lidocaine 2% into a standard syringe and attach the MAD tip. For most adults, 1 to 3 mL per nostril (20 to 60 mg) is used, staying within safe dosing limits. Have the patient blow their nose gently to clear mucus before you begin.
Position the patient lying down. If tolerated, raise the upper body slightly. Insert the MAD tip just inside the nostril, angling it toward the back of the nasal cavity (parallel to the roof of the mouth, not upward toward the forehead). Depress the syringe with a firm, quick push to generate an effective mist. Repeat on the opposite side if bilateral treatment is needed.
After delivery, have the patient remain in position for at least 30 seconds to allow the solution to coat the mucosa. The patient may taste bitterness in the back of the throat as some solution drains posteriorly. This is normal and expected.
Head Positioning for Drops and Gravity-Based Delivery
When using drops or a spray bottle rather than an atomizer, head positioning becomes critical for directing the solution to the right spot. The Brigham and Women’s Faulkner Hospital protocol for nasal lidocaine describes a specific technique:
- Have the patient lie on their back with their shoulders at the edge of the bed, head hanging down so the bridge of the nose sits below throat level.
- Turn the head 30 degrees toward the side of the headache.
- Administer the drops into the nostril on the affected side.
- Keep the head down and turned for another 30 seconds after administration.
If the headache is bilateral, repeat the process on the other side. This extended neck position uses gravity to carry the lidocaine toward the posterior nasopharynx where the sphenopalatine ganglion sits, rather than letting it drain forward or straight down the throat.
Concentrations and Dosing
Clinical studies have used lidocaine concentrations ranging from 2% to 10% for intranasal delivery, though 4% is the most commonly studied for migraine and headache applications. The volume per nostril in published trials ranges from 0.5 mL to 2 mL depending on concentration and delivery method.
The maximum safe dose of lidocaine applied to mucous membranes is 4.5 mg per kilogram of body weight, not exceeding 300 mg per single dose or 2,400 mg over 24 hours. For a 70 kg adult, that ceiling is about 300 mg total. With MAD atomization using 2% lidocaine, typical bilateral dosing of 60 to 120 mg total stays well within this range. Gauze-based methods that use 100 mg per nostril approach the upper limits more quickly, so weight-based calculations matter more with those techniques.
Onset, Duration, and What to Expect
Topical lidocaine begins numbing tissue within about 90 seconds, with full anesthesia at roughly 110 seconds on average. Patients start to notice sensation returning at around 10 minutes, but complete return of normal feeling takes closer to 22 minutes. In nearly all patients, full sensation is restored by 40 minutes.
For headache applications, the therapeutic effect can outlast the local numbness. Some patients experience relief that persists well beyond the anesthetic window, likely because interrupting the nerve signal temporarily can break a pain cycle.
Patients commonly report a bitter taste in the throat, mild burning in the nose during application, and temporary numbness in the soft palate. These are expected effects of the drug reaching the posterior nasopharynx.
Safety Limits and Contraindications
Lidocaine is contraindicated in anyone with a known allergy to amide-type local anesthetics. Beyond that, the primary safety concern with intranasal delivery is systemic absorption. The nasal mucosa is highly vascular, so lidocaine enters the bloodstream more quickly than it would through intact skin.
Signs of lidocaine toxicity include unusual drowsiness, sluggishness, shallow breathing, numbness or tingling around the mouth, dizziness, and in severe cases, seizures. These symptoms warrant immediate medical attention. Staying within the 4.5 mg/kg ceiling and using the lowest effective dose minimizes this risk substantially.
Post-Administration Instructions
Because lidocaine numbs the throat to some degree after intranasal delivery, patients should not eat or drink for at least one hour afterward. Chewing while the throat or mouth is numb creates a real risk of biting the tongue or inner cheeks, and swallowing may be impaired. Full sensation should return within 45 minutes, but waiting the full hour provides a safety margin.
For children, close monitoring after administration is essential. Watch for any medicine getting into the eyes or mouth, and observe for signs of excessive sedation or breathing changes. In pediatric settings, a single puff of 10 mg lidocaine spray has been used safely in children as young as 5 months to reduce nasal discomfort before other intranasal medications, though pediatric use should always follow weight-based dosing limits carefully.